Overview
- 46 inspections across 46 sites are on record.
- 57 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-06-12.
At a glance
Inspections
46
Sites
46
Observations
57
Career since
Mar 2023
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Johnson Research, LLC | 12 Jun 2026 | Animal Drugs & Feeds | View 483 → |
| Damaris Vega, MD | 29 May 2026 | Human Drugs | |
| Ibex Preclinical Research, Inc. | 22 May 2026 | Medical Devices & Rad Health | View 483 → |
| Mohammed M. Ansari, MD | 24 Apr 2026 | Medical Devices & Rad Health | |
| Andrew J. Galligan, M.D. | 25 Mar 2026 | Human Drugs |
Sites inspected
Johnson Research, LLCParma, United States1 insp.
Damaris Vega, MDHouston, United States1 insp.
Ibex Preclinical Research, Inc.Logan, United States1 insp.
Mohammed M. Ansari, MDLubbock, United States1 insp.
Andrew J. Galligan, M.D.Tampa, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Ruth E Medcalf5 shared
Courtney R Bratina3 shared
Habacuc V Barrera3 shared
Travis M Beard2 shared
Andrea A Branche2 shared
Iris C Macinnes2 shared
Erin M Mcdowell1 shared
Daniel P Laucks1 shared
Lan T Tran1 shared
Samson O Oluseye1 shared
Full investigator report
Get the verbatim findings behind Audrey J Yarbrough's 57 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site